Capital with a purpose.
KTR Capital is a private investment firm built to direct capital toward the science and technology shaping the future — with a particular focus on biotech companies working to make a real difference in cancer.
Built to back the science that matters.
KTR Capital was created to operate at the intersection of rigorous market intelligence, disciplined capital allocation, and deep scientific conviction. We combine a physician-led biotech edge with proprietary trading technology — directing capital toward selected biotech companies working to make a real, measurable difference in cancer.
That focus is not incidental. The firm's approach is informed by genuine clinical understanding of oncology — of drug pipelines, trial outcomes, and where the science is actually moving. It is medical insight applied as an investment discipline, paired with systematic, in-house quantitative strategies and careful risk management.
We believe differentiated firms are built on proprietary systems, tighter feedback loops, and a willingness to stay selective. Our model is designed for qualified investors who value transparency, direct access, and long-duration alignment.
At the center of an emerging bioscience hub.
KTR Capital is headquartered in Austin, Texas — one of the fastest-growing centers for life sciences, technology, and capital in the United States. Austin's expanding biosciences ecosystem, research institutions, and concentration of technical talent place the firm close to the innovation it seeks to back.
It is a fitting home for a firm built around science and technology: a city where breakthrough research, entrepreneurial energy, and serious capital increasingly converge.
Selective. Disciplined. Long-term.
We are building a firm around discipline, structural insight, capacity control, and careful capital allocation.
Proprietary Intelligence
Internal research and signal infrastructure, built and operated in-house, designed to support differentiated decision-making across markets.
Selective Relationships
We work with qualified investors and strategic partners where alignment and sophistication are clear, and we manage capacity deliberately.
Conviction-Driven Capital
We focus on high-conviction opportunities — in biotech, quantitative trading, and private equity — within a single, disciplined fund.
Start the conversation.
KTR Capital Fund I is available to accredited investors. Create an account to complete a brief qualification and explore the platform, or contact us directly.
KTR Capital Management is a Texas-based Exempt Reporting Adviser; KTR Capital Fund I, L.P. is a Texas Limited Partnership. This page is for informational purposes only and is not an offer to sell or a solicitation to buy any security. Any offer is made only to accredited investors through definitive offering documents. Investments involve substantial risk, including the possible loss of all capital.